What’s The Difference Between Ketamine Infusion Therapy & Spravato?

Ketamine Therapy & Spravato: Key Differences - Jonesboro AR

What’s The Difference Between Ketamine Infusion Therapy & Spravato?

Ketamine infusion therapy and Spravato are two treatments used for depression and other mental health conditions. While both aim to provide relief, they differ in various aspects. Understanding these differences is crucial in making an informed decision about which treatment option may be suitable for individual needs. This article explores the basics of ketamine infusion therapy, an overview of Spravato, and compares the two treatments.

Understanding Ketamine Infusion Therapy

The Basics of Ketamine Infusion Therapy

Ketamine infusion therapy involves the administration of a dissociative anesthetic called ketamine through intravenous (IV) infusion. This innovative treatment was originally developed as an anesthetic but has shown promising effects in treating conditions like major depressive disorder and post-traumatic stress disorder.

But how does ketamine infusion therapy actually work? During the therapy session, the patient is carefully monitored by a medical professional. The infusion, typically lasting around 40 minutes to an hour, delivers a low dose of ketamine. The dosage is personalized based on the individual’s condition and response, ensuring optimal results.

The Process of Ketamine Infusion Therapy

The journey towards relief usually starts with a comprehensive evaluation and discussion with a healthcare provider. This step is crucial to determine if ketamine infusion therapy is the right course of action for the individual. If deemed appropriate, the patient may undergo a series of ketamine infusion sessions, typically ranging from six to eight sessions over a few weeks.

But what can patients expect from these sessions? The effects of ketamine infusion therapy are often rapid, with some patients experiencing relief in a matter of hours or days. This rapid response sets it apart from traditional antidepressant medications, which can take weeks to show any noticeable improvement. However, it is important to note that ongoing maintenance sessions might be necessary to sustain the benefits and prevent relapse.

Potential Benefits and Risks of Ketamine Infusion Therapy

Ketamine infusion therapy has shown significant potential benefits for individuals who have not responded well to other treatment options. It provides quick relief and may even help decrease suicidal thoughts in some cases. This breakthrough treatment offers hope to those who have been living with the debilitating effects of treatment-resistant mental health conditions.

However, it is vital to approach ketamine infusion therapy with a balanced understanding of its potential risks and side effects. Like any medical treatment, ketamine infusion therapy carries certain risks. These may include temporary dissociation, increased blood pressure, and nausea, among others. It is crucial to discuss any concerns or pre-existing conditions with a healthcare provider before proceeding with the treatment, ensuring the utmost safety and efficacy.

As research continues to unfold, ketamine infusion therapy holds promise as a transformative treatment option for individuals struggling with mental health conditions. Its unique mechanism of action and rapid response rate make it a compelling avenue for those seeking relief from the burdens of depression and trauma. By understanding the basics, process, and potential benefits and risks of ketamine infusion therapy, individuals can make informed decisions about their mental health journey.

An Overview of Spravato

What is Spravato?

Spravato is the brand name for esketamine nasal spray, which is an FDA-approved medication for treating depression, specifically treatment-resistant depression. Unlike ketamine infusion therapy, Spravato does not require intravenous administration, making it more convenient for some individuals.

Developed by Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson, Spravato represents a groundbreaking advancement in the field of mental health treatment. The nasal spray format offers a non-invasive and user-friendly alternative to traditional antidepressant medications, providing hope for those struggling with persistent depressive symptoms.

How Does Spravato Work?

Spravato acts on the brain’s glutamate receptors, targeting the N-methyl-D-aspartate (NMDA) receptor. By blocking these receptors, Spravato helps regulate mood and alleviate depressive symptoms.

When administered, Spravato is rapidly absorbed through the nasal mucosa and enters the bloodstream, where it can exert its therapeutic effects on the central nervous system. The precise mechanism of action of esketamine is still being studied, but its impact on glutamate neurotransmission is believed to play a crucial role in its antidepressant properties.

Similar to ketamine infusion therapy, Spravato is administered under the supervision of a healthcare provider and requires regular monitoring. The initial treatment phase usually involves two sessions per week for the first four weeks, followed by potential adjustments in frequency.

Potential Benefits and Risks of Spravato

Spravato can be effective for individuals who have not found relief with other antidepressant medications. It has been shown to provide rapid results, with some patients experiencing improvement within a few days.

However, like any medication, Spravato may have potential side effects, including dizziness, sedation, and a dissociative feeling. It is essential to carefully follow the instructions provided by the healthcare provider and report any adverse effects promptly.

Comparing Ketamine Infusion Therapy and Spravato

Similarities Between Ketamine Infusion Therapy and Spravato

Both ketamine infusion therapy and Spravato are indicated for the treatment of depression, particularly when other treatments have not been effective. They offer rapid relief for some individuals, with effects often noticeable within a short period.

Additionally, both treatments require medical supervision during administration to ensure safety and proper monitoring. Whether it’s receiving ketamine through IV infusion or using the Spravato nasal spray, healthcare professionals play a crucial role in guiding the treatment process.

Patients undergoing ketamine infusion therapy often find themselves in a calm and relaxing environment during the procedure. The setting is designed to enhance the overall experience and promote a sense of tranquility, contributing to the therapeutic effects of the treatment. On the other hand, individuals using Spravato may appreciate the convenience of self-administration at home under the guidance of a healthcare provider, offering a different level of comfort and autonomy.

Moreover, both ketamine infusion therapy and Spravato have shown promising results in not only alleviating symptoms of depression but also in addressing conditions like post-traumatic stress disorder (PTSD) and treatment-resistant depression. This versatility in treatment options underscores the potential of these therapies to cater to a diverse range of mental health needs.

Key Differences Between Ketamine Infusion Therapy and Spravato

One of the primary differences between ketamine infusion therapy and Spravato is the mode of administration. Ketamine infusion therapy is delivered through IV infusion, while Spravato is administered as a nasal spray. The differing methods may influence factors such as convenience, administration time, and personal preference.

Another significant difference lies in their active ingredients. Ketamine infusion therapy utilizes ketamine, whereas Spravato contains esketamine, a component that is derived from ketamine but has distinct pharmacological characteristics.

Furthermore, the cost implications of ketamine infusion therapy versus Spravato may vary depending on factors such as insurance coverage, frequency of treatment sessions, and healthcare provider fees. Patients considering these treatment options may benefit from discussing the financial aspects with their healthcare team to make informed decisions based on their individual circumstances.

Making an Informed Decision: Ketamine Infusion Therapy or Spravato

Factors to Consider When Choosing a Treatment

When deciding between ketamine infusion therapy and Spravato, several factors should be considered. These may include the severity of the condition, treatment response history, convenience, individual preferences, and any potential contraindications or risks associated with each treatment.

It is essential to have a thorough discussion with a healthcare provider who can assess individual circumstances, provide guidance, and help make an informed decision based on the available options.

Discussing Your Options with a Healthcare Provider

Ultimately, the decision of whether to pursue ketamine infusion therapy or Spravato should be made in consultation with a healthcare provider. They can provide thorough information, address concerns, and help determine the most suitable treatment for individual needs. Furthermore, ongoing communication with the healthcare provider is crucial throughout the treatment process to ensure proper monitoring, adjustment of treatment plans, and evaluation of efficacy.

In Conclusion

By understanding the basics and distinguishing features of ketamine infusion therapy and Spravato, individuals can better navigate the choices and make informed decisions that align with their specific needs and preferences.

To learn what mental health treatment options are right for you, reach out to us at VIVE Infusion & Wellness today to schedule a consultation.

Share Now :